Literature DB >> 6367901

Role of renin-angiotensin system in cardiopulmonary bypass hypertension.

G E Townsend, J E Wynands, D G Whalley, P Wong, D R Bevan.   

Abstract

The role of the renin-angiotensin system in the aetiology of perioperative hypertension was studied in 15 previously normotensive patients undergoing coronary artery surgery and anaesthetized with fentanyl. Measurements of plasma renin activity were made at intervals before and during cardiopulmonary bypass (CPB). In addition, angiotensin II blockade with saralasin was used in an attempt to treat hypertension during CPB. Nine of the patients became hypertensive (increase in systemic pressure of more than 20 per cent) before CPB and although the mean plasma renin activity was higher in this group than in the normotensive patients it was within normal limits for each group. Hypertension during CPB (mean blood pressure greater than 100 mmHg at 1.8 l X m-2 flow), occurred in seven patients but was not associated with increased renin activity and did not respond to saralasin in doses up to 20 micrograms X kg-1 X min-1. It is concluded that cardiopulmonary bypass associated hypertension is not mediated by activation of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367901     DOI: 10.1007/bf03015254

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  21 in total

1.  The renin--angiotensin--aldosterone system during cardiac surgery with morphine--nitrous oxide anesthesia.

Authors:  D R Bailey; E D Miller; J A Kaplan; P W Rogers
Journal:  Anesthesiology       Date:  1975-05       Impact factor: 7.892

2.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

3.  Saralasin in human hypertension: the early experience.

Authors:  H R Brunner; J H Laragh
Journal:  Kidney Int Suppl       Date:  1979-03       Impact factor: 10.545

4.  Comparative studies of pulsatile and nonpulsatile flow during cardiopulmonary bypass. I. Pulsatile system employed and its hematologic effects.

Authors:  K M Taylor; W H Bain; K J Maxted; M M Hutton; W Y McNab; P K Caves
Journal:  J Thorac Cardiovasc Surg       Date:  1978-04       Impact factor: 5.209

5.  Hypertension following coronary artery bypass graft.

Authors:  W McIlvaine; M Boulanger; J G Maillé; B Paiement; J Taillefer; P Sahab
Journal:  Can Anaesth Soc J       Date:  1982-05

6.  Haemodynamic and plasma vasopressin responses with high-dose fentanyl anaesthesia during aorto-coronary bypass operations.

Authors:  L A Crone; N Wilson; J Ngsee; K W Turnbull; K Leighton
Journal:  Can Anaesth Soc J       Date:  1982-11

7.  Blood pressure response and plasma fentanyl concentrations during high- and very high-dose fentanyl anesthesia for coronary artery surgery.

Authors:  J E Wynands; G E Townsend; P Wong; D G Whalley; C B Srikant; Y C Patel
Journal:  Anesth Analg       Date:  1983-07       Impact factor: 5.108

8.  Fentanyl infusion anesthesia for aortocoronary bypass surgery: plasma levels and hemodynamic response.

Authors:  J S Sprigge; J E Wynands; D G Whalley; D R Bevan; G E Townsend; H Nathan; Y C Patel; C B Srikant
Journal:  Anesth Analg       Date:  1982-12       Impact factor: 5.108

9.  Systemic hypertension following myocardial revascularization. A method of treatment using epidural anesthesia.

Authors:  P F Hoar; R F Hickey; D J Ullyot
Journal:  J Thorac Cardiovasc Surg       Date:  1976-06       Impact factor: 5.209

10.  Renal function and stress response during halothane or fentanyl anesthesia.

Authors:  K Kono; D M Philbin; C H Coggins; J Moss; C E Rosow; R C Schneider; E E Slater
Journal:  Anesth Analg       Date:  1981-08       Impact factor: 5.108

View more
  2 in total

1.  Hypertension associated with cardiopulmonary bypass.

Authors:  G V Goresky
Journal:  Can Anaesth Soc J       Date:  1984-07

Review 2.  Serotonin and acute cardiovascular disorders.

Authors:  R S Reneman; P J van der Starre
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.